RxDoctor Payments Data

Pankaj Rajvanshi, MD

Gastroenterology · Renton, WANPI 1437148749

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $45,775 of the $59,716 with a category attached, or 76.7%. AbbVie accounts for 79.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $27,607 and has fallen 59.7% since, to $11,126 in 2025. Among gastroenterology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$59,716in general payments, 2019–2025

Across 51 payments — averaging $1170.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$47K
  • Boehringer Ingelheim$11K
  • Gilead$2K
  • Boston Scientific$35
  • Lilly USA, LLC$34
$5,365in research payments, 2019–2025

Across 3 payments — averaging $1788.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intercept Pharmaceuticals, Inc.$5K

What the payments were for

  • Consulting fees$11,22019%
  • Speaking & faculty fees$45,77577%
  • Travel & lodging$1,5063%
  • Food & beverage$1,2152%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie38$47,233
Boehringer Ingelheim10$10,644
Gilead1$1,770
Boston Scientific1$35
Lilly USA, LLC1$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$59,716 in reported general payments places this provider in the 95th percentile of 447 gastroenterology providers in Washington.

See all gastroenterology providers in Washington

Medicare billing

Part B allowed, 2024
$76,768
Medicare patients
193
Services billed
553

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Renton

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →